Ex vivo-generated human CD1c+ regulatory B cells by a chemically defined system suppress immune responses and alleviate graft-versus-host disease.
Bao Y, Liu J, Li Z, Sun Y, Chen J, Ma Y, Li G, Wang T, Liu H, Zhang X, Yan R, Yao Z, Guo X, Fang R, Feng J, Xia W, Xiang AP, Chen X.
Bao Y, et al. Among authors: li z, li g.
Mol Ther. 2024 Dec 4;32(12):4372-4382. doi: 10.1016/j.ymthe.2024.10.026. Epub 2024 Oct 26.
Mol Ther. 2024.
PMID: 39489917
Free PMC article.